Skip to main content

Advertisement

SpringerLink
Log in

Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility

  • Nephrology – Translational Section
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Freedman BI (2003) Susceptibility genes for hypertension and renal failure. J Am Soc Nephrol 14:S192

    Article  CAS  PubMed  Google Scholar 

  2. Kao WH, Klag MJ, Meoni LA et al (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40:1185

    Article  CAS  PubMed  Google Scholar 

  3. Freedman BI, Edberg JC, Comeau ME et al (2010) The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol 32:66

    Article  CAS  PubMed  Google Scholar 

  4. Freedman BI, Kopp JB, Langefeld CD et al (2010) The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 21:1422

    Article  CAS  PubMed  Google Scholar 

  5. Genovese G, Friedman DJ, Ross MD et al (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841

    Article  CAS  PubMed  Google Scholar 

  6. Genovese G, Tonna SJ, Knob AU et al (2010) A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 78:698

    Article  PubMed  Google Scholar 

  7. Freedman BI, Parekh RS, Kao WH (2010) Genetic basis of nondiabetic end-stage renal disease. Semin Nephrol 30:101

    Article  PubMed  Google Scholar 

  8. Zenker M, Machuca E, Antignac C (2009) Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier. J Mol Med 87:849

    Article  CAS  PubMed  Google Scholar 

  9. Brown EJ, Schlondorff JS, Becker DJ et al (2010) Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet 42:72

    Article  CAS  PubMed  Google Scholar 

  10. Kaplan JM, Kim SH, North KN et al (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24:251

    Article  CAS  PubMed  Google Scholar 

  11. Reiser J, Polu KR, Moller CC et al (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739

    Article  CAS  PubMed  Google Scholar 

  12. Freedman BI, Hicks PJ, Bostrom MA et al (2009) Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75:736

    Article  CAS  PubMed  Google Scholar 

  13. Kopp JB, Smith MW, Nelson GW et al (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40:1175

    Article  CAS  PubMed  Google Scholar 

  14. Oleksyk TK, Nelson GW, An P et al (2010) Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One 5:e11474

    Article  PubMed  Google Scholar 

  15. Kopp JB (2010) Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism? Kidney Int 78:130

    Article  PubMed  Google Scholar 

  16. Nelson GW, Freedman BI, Bowden DW et al (2010) Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet 19:1805

    Google Scholar 

  17. Vanhollebeke B, Pays E (2006) The function of apolipoproteins L. Cell Mol Life Sci 63:1937

    Article  CAS  PubMed  Google Scholar 

  18. Pays E, Vanhollebeke B, Vanhamme L et al (2006) The trypanolytic factor of human serum. Nat Rev Microbiol 4:477

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Human Genetics, Otto-von-Guericke-University Magdeburg, Leipziger Strasse 40, 39120, Magdeburg, Germany

    Martin Zenker

  2. Department of Nephrology and Hypertension, Otto-von-Guericke-University Magdeburg, Leipziger Straße 40, 39120, Magdeburg, Germany

    Peter R. Mertens

Authors
  1. Martin Zenker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter R. Mertens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Zenker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zenker, M., Mertens, P.R. Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility. Int Urol Nephrol 42, 1131–1134 (2010). https://doi.org/10.1007/s11255-010-9863-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-010-9863-z

Keywords

Search

Navigation